DLG EXPO(600826) 国泰君安·2024-11-08 06:25Investment Rating - The report maintains a rating of "Buy" for the company [4] Core Insights - The company's main business is stable, and external investments to establish subsidiaries open up new opportunities. The inclusion in the Abbott World Marathon Majors candidate events presents further growth potential [2][3] Summary by Sections Financial Performance - The company reported a revenue of 932 million yuan, a decrease of 3.29% year-on-year, and a net profit attributable to shareholders of 202 million yuan, down 16.53%. The net profit for Q3 2024 was 120 million yuan, an increase of 142.97%, primarily due to gains from fair value changes in financial assets [3] - The EPS forecast for 2024, 2025, and 2026 has been raised to 0.38, 0.40, and 0.42 yuan respectively, up from previous estimates of 0.30, 0.32, and 0.34 yuan [3] Market Opportunities - The establishment of the subsidiary "Weike Yili" emphasizes the company's focus on the AI sector, aiming to become a leading global AI ecosystem service provider. The Hong Kong subsidiary will facilitate international market expansion [3] - The Shanghai Marathon has officially become a candidate event for the Abbott World Marathon Majors, positioning it among the world's top marathon events. This recognition is expected to enhance the company's event management capabilities and visibility [3] Valuation - The target price has been adjusted to 9.49 yuan, up from the previous 7.39 yuan, reflecting a PE ratio slightly below the industry average of 24.8x for 2024 [3][4]